Peroxisomal activity drives aggressive bladder cancer phenotypes and reveals erythorbic acid as a potential therapeutic modulator. Wu Q, Zhou Y, Ou Z, Fu H, et al. Front Oncol 2026;16:1734437.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu Q, Zhou Y, Ou Z, Fu H, et al. Peroxisomal activity drives aggressive bladder cancer phenotypes and reveals erythorbic acid as a potential therapeutic modulator. Front Oncol 2026;16:1734437.
PMID: 41858347